# Mizar Therapeutics, Inc. — Form D

Mizar Therapeutics, Inc. of WOODS HOLE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-09. The offering totals $719K, of which $519K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2025-06-09
- Form: D
- Accession: 0002070986-25-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $719K
- Amount sold: $519K
- Remaining: $200K
- Investors: 6
- Date of first sale: 2025-05-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-548372

## Issuer

- Name: Mizar Therapeutics, Inc.
- CIK: 0002070986
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: PO, WOODS HOLE, MA, 02543
- Phone: 626-379-6659

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Paul Maddox | Director | Woods Hole, MA |
| Joel Smith | Director | Woods Hole, MA |
| Paul Maddox | Executive Officer | Woods Hole, MA |
| Joel Smith | Executive Officer | Woods Hole, MA |

## More

- [CIK 2070986 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2070986&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002070986-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.